PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - McDonald, Kenneth
TI  - BNP Screening, Targeted Care Reduce Heart Failure in At-Risk Patients
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 17--18
VI  - 13
IP  - 2
4099  - http://mdc.sagepub.com/content/13/2/17.short
4100  - http://mdc.sagepub.com/content/13/2/17.full
AB  - Structured screening for heart failure (HF) using measurement of B-type natriuretic peptide (BNP) followed by targeted collaborative care was effective at preventing left ventricular dysfunction and HF in a community setting. The use of biomarkers related to ventricular damage or dysfunction may improve the ability to identify individuals at risk and ultimately prevent downstream complications. Because it reflects established cardiovascular (CV) insult rather than CV risk, BNP might help identify high risk patients and help focus care where it is needed most, according to the rationale for the St. Vincent's Screening to Prevent Heart Failure study [STOP-HF; NCT00921960].